JPMorgan taps BGI Genomics COO to head China healthcare i-banking team
Street Talk | Episode 98: Regulatory scrutiny having cooling effect on community bank M&A
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Street Talk | Episode 97: Recessionary fears still keeping bank investors on the sidelines
JPMorgan Chase & Co. named Ling Zhang head of its healthcare and technology investment banking in China, Reuters reported Jan. 2.
Zhang was managing director of J.P. Morgan Securities (Asia Pacific) Ltd. before going to Chinese biotechnology company BGI Genomics Co. Ltd. to serve as COO.